Anlon Healthcare Limited (NSE:AHCL)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Manufacturing and Sale of Active Pharmaceutical Ingredients (APIs)	1.72B	1.20B	666.16M	1.13B	573.89M
Total	1.72B	1.20B	666.16M	1.13B	573.89M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
India	1.69B	1.16B	599.73M	1.01B	476.81M
Export	34.59M	38.97M	66.11M	120.26M	94.61M
Total	1.72B	1.20B	665.84M	1.13B	571.43M

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error